New Targets = Better Standard of Care

Alexander Bastian

Video Categories: Targeted Therapies

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.
October 1, 2014

The Changing Role of Pharmacists

Hear Atheer Kaddis describe how the role of the pharmacist is changing in hematology and oncology.Supported through funding from Incyte

July 25, 2018

The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.